BankInvest Biomedical Venture logo

BankInvest Biomedical Venture

Description

BankInvest Biomedical Venture makes investments in research-based biotechnology companies in Europe.

Investor Profile

BankInvest Biomedical Venture has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 25% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series C, Series B rounds (top funding stages).
  • Majority of deals are located in United Kingdom, France, Denmark.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series Unknown (38%)
  • Series C (25%)
  • Series B (25%)
  • Series D (13%)

Country Focus

  • United Kingdom (25%)
  • France (25%)
  • Denmark (25%)
  • United States (13%)
  • Sweden (13%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Biopharma
  • Oncology
  • Genetics
  • Medical Device
  • Therapeutics
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BankInvest Biomedical Venture frequently co-invest with?

Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 1
EV
Asia, Fujian, China, Taipei
Co-Investments: 1
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
BL
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 1
Advent International
North America, Massachusetts, United States, Boston
Co-Investments: 1
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 2
ODYSSEE VENTURE
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Idinvest Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Forward Ventures
North America, California, United States, San Diego
Co-Investments: 1

What are some of recent deals done by BankInvest Biomedical Venture?

F2G

Manchester, Manchester, United Kingdom

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

BiotechnologyGeneticsHealth CareMedicalPharmaceutical
Series UnknownAug 18, 2008
Amount Raised: $11,753,687
Nereus Pharmaceuticals

San Diego, California, United States

Nereus Pharmaceuticals engages in the discovery and development of therapeutics for the treatment of infectious diseases and inflammation.

BiotechnologyHealth CareMedical
Series DAug 9, 2007
Amount Raised: $45,000,000
Resistentia Pharmaceuticals

Uppsala, Uppsala Lan, Sweden

Resistentia Pharmaceuticals develops immunotherapeutic products for allergic asthma and inflammatory disorders.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series CSep 26, 2006
Amount Raised: $13,960,000
Cellectis

Paris, Ile-de-France, France

Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.

BiopharmaBiotechnologyHealth CareMedicalOncology
Series CJun 1, 2005
Amount Raised: $6,842,352
LiPlasome Pharma

Vejle, Syddanmark, Denmark

LiPlasome, a biotech company focused on oncology, provides a liplasomal reformulation of anticancer drugs on the market.

BiotechnologyHealth CareOncologyPharmaceutical
Series BMar 1, 2005
Amount Raised: $8,010,000
Cellectis

Paris, Ile-de-France, France

Cellectis is a biopharmaceutical company that develops adoptive immunotherapies for cancer.

BiopharmaBiotechnologyHealth CareMedicalOncology
Series BMay 1, 2002
Amount Raised: $7,240,061
Oxagen

London, England, United Kingdom

Oxagen is a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series UnknownDec 21, 2000
Amount Raised: $44,240,218
Genmab

Copenhagen, Hovedstaden, Denmark

Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.

BiotechnologyHealth CareManufacturingMedical
Series UnknownJun 13, 2000
Amount Raised: $40,500,000